vs
Side-by-side financial comparison of AMBARELLA INC (AMBA) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
AMBARELLA INC is the larger business by last-quarter revenue ($108.5M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). AMBARELLA INC runs the higher net margin — -13.9% vs -70.9%, a 57.0% gap on every dollar of revenue. On growth, AMBARELLA INC posted the faster year-over-year revenue change (31.2% vs 8.1%). AMBARELLA INC produced more free cash flow last quarter ($31.4M vs $-1.8M). Over the past eight quarters, AMBARELLA INC's revenue compounded faster (45.0% CAGR vs 17.7%).
Ambarella, Inc. is an American fabless semiconductor design company, focusing on low-power, high-definition (HD) and Ultra HD video compression, image processing, and computer vision processors. Ambarella's products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver and in-cabin monitoring, autonomous driving, and robotics applications. Ambarella's system on chips ...
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
AMBA vs CTKB — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $108.5M | $62.1M |
| Net Profit | $-15.1M | $-44.1M |
| Gross Margin | 59.6% | 52.9% |
| Operating Margin | -15.0% | -9.0% |
| Net Margin | -13.9% | -70.9% |
| Revenue YoY | 31.2% | 8.1% |
| Net Profit YoY | 37.2% | -557.1% |
| EPS (diluted) | $-0.35 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $108.5M | $62.1M | ||
| Q3 25 | $95.5M | $52.3M | ||
| Q2 25 | $85.9M | $45.6M | ||
| Q1 25 | $84.0M | $41.5M | ||
| Q4 24 | $82.7M | $57.5M | ||
| Q3 24 | $63.7M | $51.5M | ||
| Q2 24 | $54.5M | $46.6M | ||
| Q1 24 | $51.6M | $44.9M |
| Q4 25 | $-15.1M | $-44.1M | ||
| Q3 25 | $-20.0M | $-5.5M | ||
| Q2 25 | $-24.3M | $-5.6M | ||
| Q1 25 | $-20.2M | $-11.4M | ||
| Q4 24 | $-24.1M | $9.6M | ||
| Q3 24 | $-34.9M | $941.0K | ||
| Q2 24 | $-37.9M | $-10.4M | ||
| Q1 24 | $-60.6M | $-6.2M |
| Q4 25 | 59.6% | 52.9% | ||
| Q3 25 | 58.9% | 52.7% | ||
| Q2 25 | 60.0% | 52.3% | ||
| Q1 25 | 60.0% | 48.6% | ||
| Q4 24 | 60.6% | 58.5% | ||
| Q3 24 | 60.8% | 56.3% | ||
| Q2 24 | 60.9% | 54.6% | ||
| Q1 24 | 59.8% | 51.3% |
| Q4 25 | -15.0% | -9.0% | ||
| Q3 25 | -23.0% | -17.6% | ||
| Q2 25 | -30.1% | -23.3% | ||
| Q1 25 | -30.2% | -36.1% | ||
| Q4 24 | -30.9% | 5.2% | ||
| Q3 24 | -56.9% | -8.2% | ||
| Q2 24 | -72.4% | -18.3% | ||
| Q1 24 | -80.8% | -23.9% |
| Q4 25 | -13.9% | -70.9% | ||
| Q3 25 | -20.9% | -10.5% | ||
| Q2 25 | -28.3% | -12.2% | ||
| Q1 25 | -24.1% | -27.5% | ||
| Q4 24 | -29.1% | 16.8% | ||
| Q3 24 | -54.8% | 1.8% | ||
| Q2 24 | -69.6% | -22.4% | ||
| Q1 24 | -117.4% | -13.8% |
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.47 | — | ||
| Q2 25 | $-0.58 | — | ||
| Q1 25 | $-0.48 | — | ||
| Q4 24 | $-0.58 | — | ||
| Q3 24 | $-0.85 | — | ||
| Q2 24 | $-0.93 | — | ||
| Q1 24 | $-1.51 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.1M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $590.1M | $341.7M |
| Total Assets | $751.9M | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $174.1M | $90.9M | ||
| Q3 25 | $142.7M | $93.3M | ||
| Q2 25 | $141.3M | $75.5M | ||
| Q1 25 | $144.6M | $95.3M | ||
| Q4 24 | $127.1M | $98.7M | ||
| Q3 24 | $153.9M | $162.3M | ||
| Q2 24 | $131.8M | $177.9M | ||
| Q1 24 | $144.9M | $168.8M |
| Q4 25 | $590.1M | $341.7M | ||
| Q3 25 | $576.5M | $378.6M | ||
| Q2 25 | $572.7M | $377.6M | ||
| Q1 25 | $561.4M | $379.6M | ||
| Q4 24 | $554.3M | $395.7M | ||
| Q3 24 | $547.6M | $385.5M | ||
| Q2 24 | $555.4M | $389.1M | ||
| Q1 24 | $559.9M | $392.6M |
| Q4 25 | $751.9M | $461.5M | ||
| Q3 25 | $706.4M | $494.9M | ||
| Q2 25 | $701.9M | $493.3M | ||
| Q1 25 | $689.0M | $482.6M | ||
| Q4 24 | $670.8M | $499.5M | ||
| Q3 24 | $650.3M | $491.2M | ||
| Q2 24 | $638.7M | $483.7M | ||
| Q1 24 | $657.7M | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.3M | $-771.0K |
| Free Cash FlowOCF − Capex | $31.4M | $-1.8M |
| FCF MarginFCF / Revenue | 29.0% | -2.9% |
| Capex IntensityCapex / Revenue | 2.7% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $64.3M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.3M | $-771.0K | ||
| Q3 25 | $5.5M | $-3.9M | ||
| Q2 25 | $14.8M | $108.0K | ||
| Q1 25 | $25.4M | $-125.0K | ||
| Q4 24 | $6.6M | $2.0M | ||
| Q3 24 | $16.7M | $13.2M | ||
| Q2 24 | $-15.0M | $6.2M | ||
| Q1 24 | $-4.0M | $4.0M |
| Q4 25 | $31.4M | $-1.8M | ||
| Q3 25 | $1.4M | $-4.6M | ||
| Q2 25 | $10.2M | $-1.5M | ||
| Q1 25 | $21.2M | $-974.0K | ||
| Q4 24 | $4.1M | $1.1M | ||
| Q3 24 | $14.2M | $12.2M | ||
| Q2 24 | $-16.1M | $5.2M | ||
| Q1 24 | $-6.0M | $3.4M |
| Q4 25 | 29.0% | -2.9% | ||
| Q3 25 | 1.4% | -8.7% | ||
| Q2 25 | 11.9% | -3.2% | ||
| Q1 25 | 25.3% | -2.3% | ||
| Q4 24 | 5.0% | 1.9% | ||
| Q3 24 | 22.2% | 23.7% | ||
| Q2 24 | -29.5% | 11.0% | ||
| Q1 24 | -11.6% | 7.6% |
| Q4 25 | 2.7% | 1.6% | ||
| Q3 25 | 4.3% | 1.3% | ||
| Q2 25 | 5.3% | 3.5% | ||
| Q1 25 | 5.0% | 2.0% | ||
| Q4 24 | 3.0% | 1.6% | ||
| Q3 24 | 4.0% | 2.0% | ||
| Q2 24 | 2.1% | 2.3% | ||
| Q1 24 | 3.7% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMBA
| TW | $76.0M | 70% |
| Asia Pacific Other Than Taiwan | $20.2M | 19% |
| North America Other Than United States | $7.4M | 7% |
| Other | $5.0M | 5% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
